Adapalene abrogates erlotinib-induced skin disorder by regulating proinflammatory cytokine production from human epidermal cells

N. Miwa (Kobe, Japan), T. Nagano (Kobe, Japan), D. Tamura (Kobe, Japan), R. Dokuni (Kobe, Japan), K. Umezawa (Kobe, Japan), N. Katsurada (Kobe, Japan), K. Nakata (Kobe, Japan), M. Yamamoto (Kobe, Japan), M. Tachihara (Kobe, Japan), H. Kamiryo (Kobe, Japan), K. Kobayashi (Kobe, Japan), Y. Nishimura (Kobe, Japan)

Source: International Congress 2018 – Lung cancer: personalised medicine
Session: Lung cancer: personalised medicine
Session type: Poster Discussion
Number: 2214
Disease area: Thoracic oncology

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Miwa (Kobe, Japan), T. Nagano (Kobe, Japan), D. Tamura (Kobe, Japan), R. Dokuni (Kobe, Japan), K. Umezawa (Kobe, Japan), N. Katsurada (Kobe, Japan), K. Nakata (Kobe, Japan), M. Yamamoto (Kobe, Japan), M. Tachihara (Kobe, Japan), H. Kamiryo (Kobe, Japan), K. Kobayashi (Kobe, Japan), Y. Nishimura (Kobe, Japan). Adapalene abrogates erlotinib-induced skin disorder by regulating proinflammatory cytokine production from human epidermal cells. 2214

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: